🕵️ Candel Therapeutics, Inc. ($CADL)
SEC insider & ownership activity, last 12 months · CIK 1841387 · every row links its SEC filing
Over the last 12 months insiders sold $312K against $3.0M of open-market buying. Paul B. Manning bought $3.0M in discretionary trades (Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $3.0M (1 lots) · 3 sellers, $312K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Paul B. Manning | 1 | $3.0M | 0 | – | Feb 23, 2026 |
| Barone Francesca | 0 | – | 1 | $236K | Jun 29, 2026 |
| Tyagarajan Seshu | 0 | – | 1 | $70K | Jun 29, 2026 |
| William Garrett Nichols | 0 | – | 1 | $7K | Jul 28, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 15.0% | 13G | Feb 7, 2025 | filing ↗ | |
| Abigail P. Johnson | 15.0% | 13G | Feb 7, 2025 | filing ↗ | |
| RTW Investments, LP | 8.8% | 13G | May 15, 2026 | filing ↗ | |
| Roderick Wong | 8.8% | 13G | May 15, 2026 | filing ↗ | |
| Paul B Manning | 7.9% | 13D | Dec 16, 2024 | filing ↗ | |
| Blackrock, Inc. | 6.6% | 13G | Jul 27, 2026 | filing ↗ | |
| Anders Hove | 5.2% | 13G | Jun 30, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Seshu P Tyagarajan | $69K | Jun 29, 2026 | filing ↗ |
| Francesca Barone | $230K | Jun 29, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 19, 2026 | filing ↗ |
| Other events (8.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 19, 2026 | filing ↗ |
| Earnings (2.02) | Feb 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 19, 2026 | filing ↗ |
| Other events (8.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 14, 2025 | filing ↗ |
| Earnings (2.02) | Oct 14, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 14, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 14, 2025 | filing ↗ |
| Other events (8.01) | Oct 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 14, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2025 | filing ↗ |